CN118613260A - 类风湿性关节炎的治疗 - Google Patents

类风湿性关节炎的治疗 Download PDF

Info

Publication number
CN118613260A
CN118613260A CN202280090357.6A CN202280090357A CN118613260A CN 118613260 A CN118613260 A CN 118613260A CN 202280090357 A CN202280090357 A CN 202280090357A CN 118613260 A CN118613260 A CN 118613260A
Authority
CN
China
Prior art keywords
compound
acid
kit
combination
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280090357.6A
Other languages
English (en)
Chinese (zh)
Inventor
托马斯·恩格尔布雷希特·诺克尔德·约纳森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sinac Pharmaceutical Co ltd
Original Assignee
Sinac Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinac Pharmaceutical Co ltd filed Critical Sinac Pharmaceutical Co ltd
Publication of CN118613260A publication Critical patent/CN118613260A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN202280090357.6A 2021-11-29 2022-11-29 类风湿性关节炎的治疗 Pending CN118613260A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21211179.3 2021-11-29
EP21211179 2021-11-29
PCT/EP2022/083624 WO2023094692A1 (en) 2021-11-29 2022-11-29 Treatment of rheumatoid arthritis

Publications (1)

Publication Number Publication Date
CN118613260A true CN118613260A (zh) 2024-09-06

Family

ID=78821593

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280090357.6A Pending CN118613260A (zh) 2021-11-29 2022-11-29 类风湿性关节炎的治疗

Country Status (5)

Country Link
US (1) US20250032449A1 (https=)
EP (1) EP4440572A1 (https=)
JP (1) JP2024540673A (https=)
CN (1) CN118613260A (https=)
WO (1) WO2023094692A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025124760A1 (en) * 2023-12-11 2025-06-19 Synact Pharma Aps Treatment of subpopulation of patients with rheumatoid arthritis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3773558T (lt) * 2019-05-10 2022-09-12 Synact Pharma Aps Kompleksinis artrito gydymas

Also Published As

Publication number Publication date
JP2024540673A (ja) 2024-10-31
US20250032449A1 (en) 2025-01-30
WO2023094692A1 (en) 2023-06-01
EP4440572A1 (en) 2024-10-09

Similar Documents

Publication Publication Date Title
EP4119140B1 (en) Phenyl pyrrole aminoguanidine derivatives in combination with methotrexate for use in the treatment of arthritic disease
CN101489573B (zh) 用TACI-Ig融合分子治疗自身免疫疾病的方法
CN118613260A (zh) 类风湿性关节炎的治疗
EP3687562B1 (en) Treatment of recurrent idiopathic pericarditis by delivery of interleukin-1 receptor antagonist fusion protein
RU2828044C2 (ru) Комбинированное лечение артрита
HK40047132B (en) Combination treatment of arthritic disease
HK40047132A (en) Combination treatment of arthritic disease
US20250302804A1 (en) Resomelagon and its derivatives for the treatment of cardiovascular disease, hypertension and atherosclerosis
WO2025124760A1 (en) Treatment of subpopulation of patients with rheumatoid arthritis
Ferraccioli Drugs in Focus in Arthritis: Leflunomide
HK40035543A (en) Treatment of recurrent idiopathic pericarditis by delivery of interleukin-1 receptor antagonist fusion protein
HK40035543B (en) Treatment of recurrent idiopathic pericarditis by delivery of interleukin-1 receptor antagonist fusion protein
Alivernini et al. Drugs in Focus in Arthritis: Leflunomide
EP1778276A1 (en) Tnf-binding protein-1 in the treatment of psoriasis
HK1128426A (en) Methods for treating autoimmune diseases using a taci-ig fusion molecule

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination